SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Melania memes are digital collectibles intended to function as an expression of support for and engagement with the values embodied by the symbol MELANIA

Melania Trump

The dominant conversation centers on MELANIAs steep post-launch collapse and allegations that it is a Trump-family pump-and-dump scheme with little utility, prompting widespread criticism from holders and traders. A small minority still promotes dip-buying, a rebound, or a short squeeze, but bearish skepticism clearly dominates.

ProShares Trust II - ProShares Ultra Bloomberg Natural Gas 2x Shares

ProShares Ultra Bloomberg Natural Gas

Larger-than-average natural-gas storage builds, elevated production, and cooling weather forecasts are driving bearish sentiment around BOIL, with Freeport LNG maintenance limiting export demand. Traders remain divided between expectations of further weakness and a potential heat-driven short squeeze, while many warn that contango, roll costs, and leveraged decay amplify downside risk.

Sovereign frontier cloud for AI that builds  AI agents are starting to build and operate real software. Agentic organizations are starting to coordinate people, code, data, payments, and governance. Both need a cloud that is sovereign, tamperproof, and always on.  The Internet Computer is that cloud.  Built on more than USD 500 million in R&amp;D, ICP uses advanced blockchain technology and cryptography to run entire software systems end-to-end on the network: websites, apps, services, data, payments, and governance. Code and data are protected by the protocol, replicated across independent nodes, and cannot be silently changed by a cloud provider, backend operator, or attacker.  Cloud engines make this infrastructure sovereign. They let organizations run ICP-powered compute across chosen providers, locations, and jurisdictions while keeping the same tamperproof and always-on guarantees of the network.  This is the real demand ICP serves: sovereign frontier cloud for AI agents and agentic organizations. Agents can build and update software. Organizations can run rules, assets, and governance as verifiable systems. The result is software that stays online, keeps its data, and remains under the control of its owners.  Developers and AI agents can build on the Internet Computer with any AI assistant using the ICP skill library at skills.internetcomputer.org, or by creating apps through conversation with Caffeine AI.  Computation on ICP is paid for by converting $ICP into cycles. $ICP is also used for staking and governance through the Network Nervous System.

Internet Computer

UNDPs collaboration with DFINITY to explore sovereign cloud and AI infrastructureincluding pilots in several countries and Pakistan-related developmentis driving attention around ICP. Traders view the initiatives as potential institutional adoption, while skeptics note they remain pilots without confirmed revenue or broad usage and question ICPs tokenomics and weak price performance.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

A bearish BMF short report criticizing SELLASs REGAL Phase 3 trial design, historical controls, dilution, and valuation drove the selloff and dominated discussion. Traders are divided between dismissing it as a self-interested short thesis and worrying that the delayed 80th-event update and pending REGAL topline results could indicate weaker outcomes; no adverse company announcement has been cited.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBios completion of the first German labeling and packaging run for ANKTIVA is driving discussion about the drugs European commercial rollout and potential revenue expansion. Traders are also speculating about future UAE and Saudi approvals for broader uses such as lymphopenia, while skeptics note that those developments lack formal confirmation and point to continued short- and options-related volatility.

Salesforce, Inc. engages in the design and development of cloud-based enterprise software for customer relationship management. Its solutions include sales force automation, customer service and support, marketing automation, digital commerce, community management, collaboration, industry-specific solutions, and salesforce platform. The firm also provides guidance, support, training, and advisory services. The company was founded by Marc Russell Benioff and Parker Harris in 1999 and is headquartered in San Francisco, CA.

Salesforce Inc

Salesforces strong quarterly results, raised outlook, and expanded Anthropic partnership through Claudeforce are driving a major software-sector rerating, with traders viewing AI as a potential monetization opportunity rather than an existential threat to SaaS. Bullish sentiment and short-covering dominate, though some traders argue the move is overextended and question organic growth, buyback-driven earnings strength, and the durability of the AI thesis.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Teslas upcoming Cybercab and robotaxi rollout is the dominant catalyst, with bulls highlighting potential growth in autonomy, robotics, and energy while skeptics point to the limited supervised deployment, competition from Waymo, and elevated valuation. The debate is amplified by heavy short-dated options activity and broader volatility surrounding Federal Reserve commentary.

Air Canada engages in the provision of airline transportation services. Its services cover full-service airline, scheduled passenger and cargo services, serving more than two hundred airports on six continents. It operates through the following geographical segments: Canada, U.S. Transborder, Atlantic, Pacific, and Other. The company was founded on April 11, 1936 and is headquartered in Saint-Laurent, Canada.

Air Canada Inc. - Ordinary Shares (Voting and Variable Voting)

Air Canada Inc.

Air Canada is drawing attention after monetizing a minority stake in Aeroplan and posting better-than-expected quarterly results, with proceeds supporting debt repayment and share buybacks. Traders are largely bullish on the valuation unlock, strong travel demand and potential short covering, while skeptics remain focused on fuel costs, labor expenses and leverage.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Updated HARMONi Phase 3 overall-survival data for ivonescimab, showing a more consistent benefit across Western and Asian patients, has renewed attention ahead of the FDAs November decision. Traders remain divided over whether the survival results satisfy the FDAs statistical requirements, while concerns about dilution and funding needs weigh on sentiment.

ETF Opportunities Trust - T-Rex 2X Long MSTR Daily Target ETF

T-Rex 2X Long MSTR Daily Target ETF

A 1-for-10 reverse split has put MSTU under scrutiny, with traders debating option adjustments, liquidity and the leveraged funds ongoing decay. The broader discussion remains tied to Bitcoin and Strategy (MSTR): bulls expect a rebound if crypto rises, while bears warn that volatility, daily reset losses and repeated reverse splits could continue eroding holders.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Why Is Biogen (BIIB) Up 6.5% Since Last Earnings Report?

Biogen (BIIB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

FDA Nods Lilly-Roche's Alzheimer's Blood Test: Healthcare ETFs to Track Now 

 FDA clearance of Lilly and Roche's Alzheimer's blood test highlights a growing diagnostics market and four healthcare ETFs to watch.

Biogen: LEQEMBI IQLIK Autoinjector Available In U.S. For Early Alzheimer's

(RTTNews) - Eisai Co. (4523.T, EII.SG) and Biogen (BIIB) announced that once weekly lecanemab-irmb subcutaneous injection - LEQEMBI IQLIK - is now available in the U.S. for initiation therapy for early Alzheimer's disease in adults with mild cognitive impairment or mild dementia...

LEQEMBI IQLIK(lecanemab-irmb) Autoinjector for Initiation of Therapy Now Available in the U.S. for Early Alzheimer's Disease

LEQEMBI IQLIK(lecanemab-irmb) Autoinjector for Initiation of Therapy Now Available in the U.S. for Early Alzheimer's Disease LEQEMBI IQLIK(lecanemab-irmb) Autoinjector for Initiation of Therapy Now Available in the U.S. for Early Alzheimer's Disease PR Newswire TOKYO and CAMBRIDGE, Mass., Aug. 24...

Should You Buy, Sell or Hold Biogen Stock After a 9% Rise in a Month?

BIIB's newer drugs, M&A activity and pipeline progress are fueling its turnaround, but declining MS sales remain a key risk.

Can ABBV's Neuroscience Drugs Drive Growth in the Second Half of 2026?

AbbVie's neuroscience franchise posts strong first-half growth, with Vyalev accelerating and tavapadon poised to add another potential growth driver.

DNLI Q2 Loss Narrows, Avlayah Sales Drive Strong Launch Momentum

Denali Therapeutics narrows Q2 loss as Avlayah sales top estimates, with strong launch traction and pipeline updates shaping its outlook.

Stoke Therapeutics to Present at the Canaccord Genuity 46th Annual Growth Conference

Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the bodys potential with RNA medicine and has a lead investigational medicine, zorevunersen, in development as a first-in-class potential disease-modifying treatment for Dravet...

IONS Beats Q2 Earnings & Sales Estimates, Reiterates '26 Outlook

Ionis beats Q2 revenues and earnings estimates as commercial growth offsets tough comparisons, while reaffirming its 2026 outlook.

Why Biogen Stock Topped the Market Today

Key PointsIt handily beat analyst estimates on both the top and bottom lines...

Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for the treatment of MS, SPINRAZA for the treatment of SMA, ADUHELM for the treatment of Alzheimer's disease, and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.

Biogen Inc

BIIB Stock On Track For Worst Day In 2 Years After RBC Questions If Alzheimer’s Drug Benefits Will Replicate In Further Study

Equity

Bearish Sentiment

Track BIIB stock price, charts, news and real-time market activity on Stocktwits. Join the BIIB message board to follow investor discussions, retail trader sentiment, bullish and bearish signals around Biogen Inc stock.

BIIB Stock Price Today - Biogen Inc News, Charts, Retail Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

The S&P 500 ($SPY) is headed towards a positive week. What do you think the index's return will look like next week? Vote and explain your reasoning in the comments.

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Feed

News

Sentiment

Earnings

Fundamentals

Info

BIIB Biogen Inc

Fundamentals

Connect Stocktwits to ChatGPT

Latest BIIB News